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Towards the Characterization of Biological Nanoparticles 
SILVER JÕEMETSA 
Department of Physics 
Chalmers University of Technology 
Abstract 
Lipids are integral to all forms of life. Both cells and the majority of particles involved with living systems are 
enveloped by a lipid membrane, which protects their content from the external environment while simultaneously 
controlling molecular transport using membrane-embedded proteins. A subset of these particles are known as 
biological nanoparticles (BNPs), including extracellular vesicles, exosomes and viruses. BNPs are known to 
transfer genetic material during cellular communication, but many aspects of the mechanisms regulating their 
various functions remain unknown. Progress within this scientific discipline is hampered by their small size 
(between 50 and 200 nm in diameter) and significant biomolecular heterogeneity, making both quantitative 
nanoparticle analytics and functional characterization, highly demanding tasks. 
To overcome the challenges of BNP characterization, we constructed an approach to identify the mechanism 
by which lipid vesicles are spontaneously converted into a planar supported lipid bilayer (SLB) on glass surfaces 
(Paper I). Total internal reflection fluorescence (TIRF) microscopy was used to track and temporally resolve the 
rate of vesicle adsorption, the onset of supported lipid bilayer (SLB) formation and the kinetics of their growth 
into a continuous SLB, through the use of a small fraction (1/100) of labelled lipid vesicles. It was found that the 
SLB formation processes was initiated by the merger of multiple small SLB patches at appreciably high vesicle 
coverage. In addition, the subsequent growth of SLB patches was, for the first time, shown to occur via a gradual 
increase in the average front velocity. Paper II focuses on quantifying both the size and molecular content of 
different types of BNPs. This was accomplished by tethering BNPs of varying complexity, to a fluid SLB formed 
on the floor of a microfluidic channel. By moving the BNPs with an applied hydrodynamic shear flow and by 
determining both the Brownian and directed motion using single particle tracking analysis, it was possible to 
determine the hydrodynamic radii for each BNP. Furthermore, imaging the BNPs using TIRF or epi-microscopy, 
made it possible to simultaneously determine the extent of fluorescent label attachment, which was specifically 
used to address how the incorporation efficiency of the membrane-staining dye spDIO depends on the size of the 
BNP. 
The insights gained on the SLB formation processes and BNP characterization are fundamental for the future 
development and advancement of novel techniques aimed at probing the molecular interaction between BNPs and 
cellular membranes. 
Keywords: supported lipid bilayer, TIRF microscopy, diffusion, size determination, lipophilic dyes, 
microfluidics 
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Introduction 
 
“The oldest and strongest emotion of mankind is fear, and the oldest and strongest kind 
of fear is fear of the unknown.” – H. P. Lovecraft 
Life is a complex interplay of various physical and chemical processes that are integral to 
maintaining life, facilitating growth and preventing disease. Debilitating and fatal diseases that 
exist without a cure threaten this balance and consequently our well-being, be it cancer, viral 
infection or neurodegenerative disorders, such as Alzheimer’s disease (AD). AD is an 
increasingly common, fatal and incurable neurodegenerative disorder that causes impairments 
in memory and intellectual function of about approximately 50 million people worldwide [1]. 
Current treatment methods employed to treat AD are capable of suppressing symptoms and 
slowing the progression of the disease, but for such techniques to be effective, early 
identification and diagnosis is paramount. Since the biggest cost for AD comes from continued 
patient support and care once the disease has already progressed, there is an urgent need for the 
development of new technologies that are capable of detecting the disease prior to symptoms 
being prevalent. It is hypothesized that precise and sensitive BNP analysis techniques may 
contribute to improved detection for AD, since this will facilitate enhanced understanding of 
their role in the disease and direct the design of novel diagnostic tools.  
One of the common factors involved in these diseases are small, nano-sized objects of 
biological origin, called biological nanoparticles (BNPs). Many of these particles are enveloped 
by a lipid membrane, thus sharing similarities with the host cell’s plasma membrane. This 
membrane, containing various phospholipids, proteins and carbohydrates, protects the internal 
content from the external environment. BNPs are responsible for a multitude of functions in 
the body, ranging from the aforementioned pathological conditions such as viral infection [2] 
to intercellular communication [3]. Furthermore, these BNPs have been proven to be natural 
and effective carriers of bioactive molecules, such as miRNA, mRNA, DNA, lipids, and 
proteins. This combination of a biocompatible envelope with the ability to carry bioactive cargo 
makes them an attractive target as or inspiration for drug delivery carriers. 
Extracellular vesicles (EVs) constitute one example of such vessels, excreted from every 
cell type into body fluids such as plasma, urine and saliva [4]. They are highly heterogeneous 
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and believed to be involved in the progression and infection steps of a multitude of diseases, 
such as cancer [5] and different neurological conditions [4,6]. For instance, EVs may be 
involved in transferring proteins associated with AD between cells, thus causing accumulation 
and aggregation of protein in otherwise healthy cells [6]. There are also recent findings 
suggesting that various viruses are transmitted as viral cargo inside EVs [7,8]. Consequently, 
their abundance and involvement in various biological processes makes EVs relevant as 
diagnostic biomarkers. In order to gain insight on how they contribute to the development of 
disease, as well as cellular function, it is of relevance to investigate the huge compositional 
heterogeneity of BNPs, which would enable their future use both as diagnostic biomarkers or 
novel therapeutic delivery vehicles. However, the combination of nano-scale size (typically 50 
to 200 nm in diameter) and high molecular heterogeneity makes the characterization of these 
nanoparticles rather difficult [9]. 
This thesis work puts focus on the use and development of a new nanoparticle size 
determination tool that in addition to size of BNP, has been shown capable of determining both 
molecular content [10] and deformation [11] when propelled using a hydrodynamic force after 
being tethered to a mobile supported lipid bilayer (BNP). In order for the particles to move 
unobstructed, a defect-free highly reproducible supported lipid bilayer (SLB) is essential. To 
achieve this goal, total internal reflection fluorescence (TIRF) microscopy was used to monitor 
the kinetics of vesicle adsorption and subsequent rupture into individual lipid patches on planar 
surfaces with the objective to gain insight on the mechanism of SLB formation (Paper I). The 
types of SLBs investigated in Paper I, were in Paper II used as a two-dimensional fluid 
interface, to which BNPs of varying complexities were tethered, with the aim to address how 
the incorporation efficiency of dyes depends on the size of BNPs. More specifically, it has been 
the aim of this thesis work to compare artificial lipid vesicles, native-membrane vesicles and 
the enveloped virus HSV1; however, the majority of experiments that so far succeeded were 
designed to address how the incorporation efficiency of the membrane-staining dye spDIO 
compare with lipid-based dyes for synthetic vesicles.  
The objective of this thesis is to provide the foundation for the experimental and analytical 
work leading up to the results presented in the appended papers. Specifically, Chapter 1 
discusses lipid vesicles, SLBs and BNPs in more detail. Chapter 2 gives an overview of the 
most commonly used nanoparticle characterization tools for BNPs listing their unique strengths 
and limitations with an emphasis on size determination. Chapter 3 includes the principles for 
the methods used in this research with an emphasis on two-dimensional flow nanometry. 
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Chapter 4 summarizes and discusses the results of the appended papers. Finally, Chapter 5 
concludes this thesis with an outlook for future and ongoing research plans. 
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1 Background 
1.1 Phospholipids and self-assembly 
Lipids are amphiphilic molecules that are characterized by a unique molecular structure 
comprised of a hydrophilic (polar) head-group attached to hydrophobic (non-polar) alkyl 
chains or ‘tail-groups’[12]. Lipids are essential to all forms of life and the functional properties 
of each is controlled by the chemical nature of their head-group and the length, number and 
saturation of the tail groups [13]. 
Of significant interest are phospholipids (phosphoglycerides), which are the main 
constituents of biological cell membranes and are, thus, essential for regulating cellular 
processes, function and health [14,15]. The plasma membrane constitutes a two-dimensional 
medium made up of a phospholipid bilayer, in which many different biological molecules, such 
as for example transmembrane proteins, are dissolved in. Owing to its unique structure, the cell 
membrane acts as a protective vessel for cell organelles separating the intracellular and 
extracellular spaces, while its semi-permeable properties facilitate transport of specific 
nutrients and waste products into and out of the cell [16]. The latter function, which is crucial 
for cellular communication, depends critically on key proteins and lipids that are embedded 
within the phospholipid bilayer.  
Phospholipids are structurally comprised of two fatty acid groups linked to a glyceryl 
backbone [17]. Unlike other lipids such as triglycerides, the final glycerol hydroxyl group is 
replaced for a phosphate head-group, rather than a fatty acid chain (Figure 1). In biological 
membranes, hydrocarbon tails typically contain 10 to 18 carbons per chain, which are linked 
together by single bonds (saturated) or double bonds (unsaturated). 
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Figure 1. (a) Schematic representation of the phospholipid molecule POPC depicting the polar head-
group, non-polar tail-groups, fatty acid chain saturation and additional chemical units. (b) A simplified 
illustration of a phospholipid. 
To minimize the free energy when dispersed in an aqueous solution, the hydrophilic head 
of lipids screen the hydrophobic tails by spontaneously forming aggregates, referred to as the 
“hydrophobic effect” [18]. The spontaneous organization process of lipids (and other 
amphiphiles) from a disordered state to an ordered or semi-ordered arrangement is a 
thermodynamically driven process referred to as “self-assembly”. Exposure of water molecules 
to the non-polar component of lipid molecules contributes a reduction in H-bonding between 
water molecules [19]. If the hydrophobic molecule is small, water molecules salvage the lost 
H-bonds by forming cages that envelope the molecule without terminating any bonds, known 
as “hydrophobic solvation”. However, this interaction between water molecules near a 
hydrophobic interface is highly thermodynamically unfavorable, because the newly formed 
configurations have an increased degree of order, which in turn corresponds to a reduction in 
entropy. All systems strive towards increasing the entropy and thereby contributing to 
minimizing the Gibbs free energy (∆ܩ) of the system, given by: 
 ∆ܩ ൌ ∆ܪ െ ܶ∆ܵ , 1.1.1
where ∆ܪ is the change in enthalpy and ܶ∆ܵ is the change in entropy. It should be noted that 
for a spontaneous process, such as self-assembly, to occur, the change in free 
energy	∆ܩ	must	be ൏ 	0. Despite the self-assembly of lipid molecules into an organized lipid 
membrane contributes to a lowering of the entropy, the overall entropy increases ሺ∆ܵ ൐ 0ሻ due 
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to release of ordered water around the hydrophobic tails, and accordingly the free energy is 
reduced. It should also be noted that the change in enthalpy (∆ܪ) is negligible compared to the 
ܶ∆ܵ term [20]. Hence, lipid molecules spontaneously self-assemble into various organized 
structures in aqueous media in order to ‘hide’ their hydrophobic tails. 
The type and geometries of colloidal structures formed by lipid molecules is determined 
by the effective head-group area, critical chain-length and hydrocarbon volume of the lipids 
[13]. This can be stipulated by relating the shape of the amphiphile to the critical packing 
parameter (CPP): 
 ܥܲܲ ൌ ܸܣܮ , 1.1.2
where ܸ is the volume taken by the hydrophobic (tail) part, ܣ is the effective surface area of 
the head-group and ܮ is the length of the tail-group. Single-chained lipids with bulky head-
groups, defined by ܥܲܲ ൏ 0.5, such as the common detergent sodium dodecyl sulfate (SDS), 
tend to form micelles; phospholipids with two tails and a fairly large head-group, defined by 
0.5 ൏ ܥܲܲ ൏ 1	tend to form bilayers and vesicles; and lipids with large hydrophobic tails, 
defined by	ܥܲܲ ൐ 1, prefer to form reverse crystal phases, such as inverted micelles [20]. Most 
phospholipids have a cylindrical shape i.e. CPP ~ 1, and therefore tend to form lipid bilayer 
structures. As the edge of such bilayer structures are energetically unfavorable, they tend to 
adopt a closed spherical shape that encapsulates an aqueous volume inside the membrane, often 
named lipid vesicles or liposomes. However, the CPP and consequently the geometry of the 
self-assembled lipid based structure depends on numerous parameters, such as electrolyte and 
lipid concentration, pH or temperature, as they will influence the interactions between the lipid 
aggregates and also the intermolecular forces within each aggregate.  
1.2 Vesicles and supported lipid bilayers  
Colloidal structures composed of lipids arranged within a lamellar or bilayer structure are 
commonly referred to as lipid vesicles or liposomes. Vesicles may be artificially created or 
naturally occurring and are typically classified according to their size and number of bilayers. 
That is, vesicles may be classified as small (10-100 nm), large (100-1000 nm) and giant vesicles 
(larger than 1 μm), and as either uni- or multi-lamellar. The hydrophobic interior of lipid 
bilayers is a relatively homogeneous region of hydrocarbon chains, whereas the exterior 
comprises of the hydrophilic head-groups, which orient towards the aqueous medium. The 
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bilayer sheets are held together by hydrophobic interactions, the unusually strong entropically 
driven attraction between non-polar molecules, or regions, in water [20,21].  
In order to gain insights into cellular processes and activities that are fundamental for cell 
survival, considerable research focus has, in recent decades, been directed towards analyzing 
the molecular interactions in and between lipid bilayer membranes. However, an overall lack 
of experimental techniques suitable for detailed investigations of such interactions has made 
progress relatively slow. One attractive approach to investigate key biophysical features of 
biological cell plasma membranes that meets the requirements of many high-end analytical 
tools is to use supported lipid bilayers (SLBs). Such SLBs are excellent model systems that 
retain two-dimensional fluidity, while providing reduced complexity and greater stability for 
the lipid membrane compared with cell membranes. This 2D membrane fluidity is believed to 
be maintained by a 10–20 Å layer of trapped water between the substrate and the bilayer [22–
24]. This is also one reason why SLBs can harness the power of surface-specific and sensitive 
analytical techniques to derive novel insights into cellular membranes e.g. atomic force 
microscopy [25], fluorescence microscopy [26], quartz crystal microbalance, surface plasmon 
resonance [27] among others [28]. However, owing to the reduced complexity, it is crucial to 
well-characterize these native membrane mimics to accurately represent the appropriate 
membrane function for a specific application. Thus, significant efforts have been invested to 
characterize the formation mechanism under various conditions [29–34]. In this thesis work, 
the SLB formation process on borosilicate glass was investigated in paper I. SLBs are also 
excellent environments to incorporate linker molecules such as cholesterol-DNA in order to 
study binding [35] or even use the same SLB-linker system to preserve and study the mobility 
of tethered NPs [36]. This system was used in Paper II with various BNPs tethered to a fluid 
SLB to gain insight on their properties.  
1.2.1 Formation techniques of SLBs 
Under certain conditions, it is possible to adsorb lipid vesicles onto surfaces, and thus convert 
them into SLBs with a typical thickness of 4 to 5 nanometers (Figure 2). The ability to do so is 
dependent on temperature, properties of the lipid vesicles, the ionic strength of the surrounding 
solution and the properties of the surface [32]. In order to form SLBs with low defect density 
and high mobility, the surface should be hydrophilic, smooth and clean [37]. 
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Figure 2. The cross-section of a vesicle (left). A supported lipid bilayer (right).  
The historically predominant methods for surface deposition of lipid bilayers were 
Langmuir–Blodgett (LB) and Langmuir-Schaefer (LS) [34,38], while more recent methods 
include solvent-assisted lipid deposition [39] and a method where freeze-thawing is used to 
induce vesicle rupture and subsequent SLB formation [40]. The most popular SLB formation 
method, which was also used in this thesis work, is the adsorption and fusion of vesicles [41,42] 
on silica-rich surfaces such as borosilicate glass. In this case, vesicles approach the surface via 
diffusion from the bulk and adsorb if the surface-vesicle interaction is favorable. Although 
vesicles can occasionally rupture into small bilayer patches at a relatively low vesicle coverage, 
the SLB formation is initiated when a fairly high vesicle coverage is reached, after which they 
start to rupture into small patches that initiate growth and the auto-catalytic SLB formation 
cascade [27]. In Paper I, the aforementioned observations were investigated in detail by 
following the growth kinetics of individual SLB patches from the adsorption and rupture of 
vesicles. 
1.3 Biological Nanoparticles 
Biological nanoparticles (BNPs), such as extracellular vesicles, exosomes and viruses are 
involved in a multitude of key biological processes, including cellular communication and viral 
infection; the detailed molecular mechanisms of which are not yet understood. Accordingly, 
the characterization of BNPs and their associated processes has recently emerged as a focus 
area for the improved understanding of fundamental processes that control cellular health. 
Furthermore, BNPs have been proven to be natural and effective carriers of various bioactive 
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molecules, such as mRNA, DNA and proteins within the membrane envelope. Therefore, 
insights derived from investigations directed towards BNPs can be harnessed for biomimetic 
development of novel therapeutic delivery vehicles. 
1.3.1 Viruses 
Viruses are complex molecular machines capable of infecting all cellular life. Virus particles 
vary considerably in size and shape, ranging from 20 nm to 400 nm in diameter. Genetic viral 
material, composed of either DNA or RNA, is encapsulated within a protein capsid, which 
protects the genome from the extracellular environment. The protein capsid is in many cases 
enclosed within a lipid membrane that is derived from the outer plasma membrane of host cells 
or from one of the inner cellular membranes. As viruses are small nano-machines that are 
incapable of self-replication, they ‘hijack’ the replication machinery of cells by attaching and 
penetrating the cellular membrane and mixing their genetic material with the host cells genome 
[43]. In doing so, replication of the viral genome is facilitated and consequently the host cell is 
turned into a virus factory. Some viruses can even lead to permanent genetic changes of 
infected cells, leading to the development of cancer and other debilitating diseases [44].  
In this thesis work, the membrane-enveloped herpes simplex virus type 1 (HSV1) was 
investigated with respect to the dependence on membrane staining as a function of virus size. 
Based on recent estimates, HSV1 has infected over 67% of the global population [45], and is 
believed to enter their host cells through fusion between its viral envelope and the plasma 
membrane, whereby the host cell is usually killed in the viral replication process [46]. Virus 
attachment is mediated by specific glycoproteins on the surface of the virus, which bind to 
receptors/sugar molecules on the cell surface [47], facilitating transmission of HSV1 between 
the host cells. Since the viral entry is mediated by membrane fusion through the binding of 
protein ligands to cell-surface receptors, this opens up a possibility to monitor virus binding to 
cell membrane mimics (see section 1.2) combined with advanced surface-based 
characterization techniques (see section 2) that can effectively monitor this process. As 
previously discussed, fluorescent microscopy techniques enables single-vesicle tracking of 
BNPs bound to supported cell-membrane mimics, given that HSV1 have been successfully 
labelled with suitable fluorophores, such as yellow-fluorescent protein (YFP) by genome 
modification [48]. However, this modification may affect the virus. Furthermore, the labelling 
efficiency and spatial distribution of YFP is only assumed to be constant and reproducible. 
Therefore, in this study, we have used an alternative labeling method, by directly targeting the 
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viral membrane using spDIO [49] and in Paper II the foundations for being able to investigate 
the labeling efficiency versus virus dimension.  
1.3.2 Extracellular vesicles 
Extracellular vesicles (EVs) are cell-secreted vesicles capable of carrying different cargo, such 
as lipids, proteins, DNA, mRNA and miRNA and are present in all body fluids [4,50]. These 
nanovesicles have been identified to play an important role in a variety of biological processes, 
including pathological conditions such as cancer and different neurological conditions, and 
have even been proposed to represent a common route for transport of neurodegenerative 
disease-related proteins and nucleic acids [6]. Specifically, transfer of proteins via exosomes 
from diseased cells to healthy cells frequently leads to accumulation and aggregation of the 
protein in the target cell, which is linked to the pathogenesis of many neurodegenerative 
diseases, such as Alzheimer’s [6].  
EVs are heterogeneous both in size and composition, with sizes ranging from 40 nm to 
1 µm [51]. EVs include distinct subtypes such as exosomes, microvesicles and oncosomes 
(released by cancer cells) [52]. Exosomes, containing miRNA and mRNA, have been shown 
to transfer the genetic content which upon delivery can be translated to proteins by the receiving 
cells [53]. There are also reports suggesting that EVs can in fact spread viral cargo such as 
HSV1 in their envelope, which can be taken up by healthy cells, leading to viral infection [7]. 
Furthermore, studies have demonstrated that EV release kinetics from cancer cells varies 
considerably compared with healthy cells [5]. Therefore, EVs serve as promising biomarkers 
for a multitude of debilitating diseases and may also guide the development of novel 
therapeutic delivery systems based on their mode of action.  
Consequently, in order to determine how these BNPs mediate biological processes and 
how EV malfunctioning contributes to the development of neurodegenerative and other 
diseases, there is a need to develop effective bioanalytical tools for improved analysis. Despite 
the existence of several bioanalytical tools for investigations of single nanoparticles, which will 
be introduced in the next chapter, precise determination of both size and content of each 
individual EV is rather difficult [9]. Preliminary measurements of EVs size distribution 
employing 2DFN (see section 3.3.2) and a high-throughput nanodevice [54] are ongoing, with 
more in-depth discussion provided in the Future Outlook section.  
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1.3.3 Native membrane vesicles 
Since exosomes vary in composition, based on the producer cell type [55], and exhibit complex 
structures that are difficult to characterize, simpler systems are helpful for the development of 
new single nanoparticle analytical tools. Native membrane vesicles (NMVs) are one such 
simplified BNP systems that can be produced in vitro from the plasma membrane of a cell, 
while retaining the membrane components of the parent cell: lipids, proteins, carbohydrates 
[56,57]. Hence, the membrane of NMVs mimics closely the membrane composition of 
exosomes, since it is also derived from the host cell in which it was released from [6,58]. 
However, unlike exosomes, NMVs are easy to harvest from host cells with several simple 
ultracentrifugation steps [56], while still acting as a more closely related exosome model 
compared to synthetic vesicles. These simpler, native BNP were in this thesis work utilized as 
a model system that acted as a precursor for exosome characterization. Specifically, it was the 
intention to compare the size determination of NMVs with that of HSV1 and synthetic vesicles. 
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2 Nanoparticle Analytics 
As mentioned in the previous chapter, a multitude of quantitative methods exist to characterize 
BNP properties, especially size. The predominant technique for the last few decades to gain 
insight on particle properties has been electron microscopy. However, certain limitations, 
especially with respect to cumbersome sample preparation, low throughput and high costs, 
have called for the development of complementary techniques. We will herein give an 
overview of these most commonly used BNP characterization methods (Table 1). 
The traditionally used standard for single particle analytical techniques is considered to be 
electron microscopy (EM), as it allows a direct read-out of the size and structural properties. 
Images in EM are created from accelerated electrons, that after being transmitted or scattered 
by a sample, hit an electron detector, which due to the short wavelengths of electrons enables 
sub nm resolution[59]. Since EM experiments are conventionally performed in high vacuum, 
and since liposomes, virus particles and other BNPs do not withstand dehydration, metal 
staining and fixation techniques are often required, which in turn changes the size and 
morphology of the sample [60]. This limitation can be overcome by using cryo-electron 
microscopy (cryoEM), which makes use of neither staining nor fixation protocols. Instead, a 
thin film of the NP suspension is spread on a EM support grid and thereafter submerged into 
liquid nitrogen, which rapidly freezes the water into amorphous ice without forming ice 
crystals[61]. This process both preserves the material in a native-like state and protects the 
sample from radiation damage. CryoEM has been employed successfully to characterize 
individual viruses [60] vesicles [62] and EVs [63–65] to gain insight on both their structural 
properties and size. In addition to direct structural information, labelling of EVs with antibody-
modified gold nanoparticles has been employed to identify sub-populations in the EV 
preparation [64]. However, the low throughput, complicated sample preparation protocols, 
long measurement times, and high cost are all limiting factors to make cryoEM a standard BNP 
analysis tool [66]. A major limitation is high variance due to low sample size, especially for 
heterogenous EV samples, as only a limited number of images can be taken in a reasonable 
amount of time [65].For example, different properties of nanoscale objects can be extracted by 
probing them with light. One such method is flow cytometry (FCM), which is used routinely 
to analyze single cells and smaller particles in the sub-micrometer range [67]. Most flow 
cytometers work in both scattering and fluorescence mode which combined with 
immunolabeling allows the structure to be correlated with biomolecular composition [68], 
although information on size requires that the dependence of the scattering signal on refractive 
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index and size is known. In FCM, cells or particles in a hydrodynamically-focused fluid stream 
are illuminated by a laser. Ideally, each cell or particle passes a laser beam one at a time, from 
where the scattering and fluorescence signals are measured. Since the measured optical signal 
is dependent on both the size of the particle and its refractive index, this poses one additional 
limitation, namely that smaller particles will not scatter sufficiently to be detectable during 
their transit through the illumination volume [69]. This is evident from the fact that the majority 
of conventional cytometers only detect individual polystyrene beads with a size larger than 
~300nm [59,65], while sub-200 nm BNPs, such as viruses and exosomes, remain at the 
detection limit of conventional flow cytometers due to their weak scattering and fluorescence 
signals [70]. 
In response to this shortcoming other methods have been developed, such as dynamic light 
scattering (DLS) [71], where the size distributions of NP ranging between a few nanometers to 
several microns can be determined [59], with an impressive limit of detection of down to about 
1 nm [72]. In DLS, a dilute suspension containing monodisperse NPs undergoing Brownian 
motion is illuminated with a focused laser beam [73]. The illuminated NPs scatter light in all 
directions, which due to their Brownian motion within the illuminated volume leads to 
temporal fluctuations that depend on particle size. Owing to its broad range of detectable sizes, 
DLS is used routinely as a high-throughput and sensitive method for accurate size 
determination [69]. However, for BNP which possess high molecular and dimensional 
heterogeneity, such as EVs, it remains difficult to accurately determine their size, which is 
basically because the intensity fluctuations become predominantly influenced by the presence 
of larger particles [59]. Due to the high heterogeneity and nano-scale size of BNPs, it is 
important to study these particles on the individual level. 
Nanoparticle tracking analysis (NTA) is today one of the most commonly used optical 
methods for nanoparticle size determination, especially for BNPs such as extracellular vesicles 
[67] and viruses [74], reaching down to the 50 nm size regime [75]. The underlying principle 
behind NTA is similar to that of DLS, where particles undergoing random motion in a 
suspension are illuminated by a focused laser beam. The scattered (or fluorescent) light induced 
by the particles is then temporally imaged using an objective fitted to a conventional optical 
microscope, being placed above the sample [76]. However, in contrast to DLS, the imaging 
mode of NTA makes it possible to analyze the nanoparticles individually, allowing their size 
to be extracted from their 3-dimensional movement. Unlike DLS, NTA copes better with 
polydisperse samples, however the quantitative determination of scattering and fluorescent 
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intensities remain difficult to quantify, since the particles are free to diffuse in and out of the 
focal plane [70]. NTA was in this work used routinely for BNP size determination, and is 
discussed in further detail in the Methods section. 
Since FCM, DLS nor NTA are best suited to determine scattering / fluorescence intensity 
or size and do not offer a possibility to unambiguously quantify multiple properties on the level 
of single nanoparticles, there exists a need for analytical concepts that enable multi-parametric 
analysis of BNPs. One such method is two-dimensional flow nanometry (2DFN) [10], which 
offers a detection limit in the sub-30 nm range while simultaneously offering the possibility 
quantify the scattering / fluorescence intensity by  confining them close to a liquid-solid 
interface in a microfluidic setup. This method was further developed and used in Paper II to 
quantify the efficiency by which BNPs can be labeled with membrane-specific dyes, and will 
be therefore discussed more thoroughly in the Experimental Methods section. 
 
Table 1 Comparison of the bioanalytical methods discussed in this chapter 
Method Limit of Detection Principle 
Mode of 
measurement Comments 
CryoEM <1 nm electron transmission direct, individual arduous sample preparation, low statistics 
FCM 200 nm light scattering indirect, individual multi-parametric 
DLS 1 nm  diffusion indirect, ensemble monodisperse samples, relative size  
NTA 50 nm diffusion indirect, individual polydisperse samples 
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3 Experimental Methods 
3.1 Total Internal Reflection Fluorescence Microscopy 
Biological nanoparticles, such as lipid vesicles and other similarly sized objects, cannot be 
visualized directly with conventional optical microscopy, due to the Abbe diffraction limit as 
the Airy peaks which arise from each molecule are not separated. Consequently, fluorescent 
microscopy has been a widely-used method to by-pass the aforementioned issue to visualize 
and study these nanometer-scale entities. Fluorescent microscopy employs fluorescent 
molecules, i.e. fluorophores1, for imaging. Importantly, fluorophores can be readily conjugated 
to molecules such as antibodies and lipids, allowing them to be visualized. A fluorophore is a 
molecule which has an energy gap usually in the visible range. When a fluorophore absorbs an 
incoming photon with an energy corresponding to the gap, an orbital electron is brought from 
the ground state S0 to the first excited singlet state S1. This excited state is unstable with a 
short lifetime, typically in the range of 10-7 to 10-9 s. In order to lower its energy, the electron 
will relax down to the ground state either radiatively or non-radiatively, each with a certain 
probability. The radiative process from S1-S0 with the re-emission of a photon is called 
fluorescence (Figure 3b) [77].The re-emitted photon has a longer wavelength (lower energy) 
than the absorbed, since a small portion of the absorbed energy is converted into vibrational 
energy, i.e. dissipated as heat. All of this is best illustrated on a Jablonski diagram (Figure 3a) 
[78]. This shift between the excitation wavelength and the emission wavelength of the 
fluorophore can be utilized for imaging purposes, which was a breakthrough in 1911 [79].   
Many different kinds of fluorescence microscopy exist, including confocal laser scanning 
microscopy [80,81], stimulated emission depletion microscopy [82], and total internal 
reflection fluorescence microscopy [83], which was the main tool used in this research. Total 
internal reflection fluorescence (TIRF) microscopy is an extension of conventional 
fluorescence microscopy, specialized to illuminate only a thin layer on a substrate surface. This 
technique has been a multifaceted/widely used tool since its invention by Axelrod et al during 
the 1980s [84] and is based on light travelling between two media with different optical 
densities (n) in the total internal reflection regime. When a beam of light travels from an 
optically denser medium and hits the sample interface at an incident angle Θ௜௡௖௜ௗ௘௡௧ larger than 
                                                 
1 For a molecule to fluoresce, certain conditions have to be met, such as high rigidity of the molecule, the 
presence of electron-donor species, and naturally the molecule has to absorb the excitatory light and favor radiative 
transitions.   
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the critical angle	Θ௖௥௜௧௜௖௔௟ , all light is reflected at the interface. This mechanism is governed 
by Snell’s law, in the case where the angle of refraction becomes 90°: 
Θ௜௡௖௜ௗ௘௡௧	 ൐ Θ௖௥௜௧௜௖௔௟ ൌ arcsin ቆ ݊௟௢௪݊௛௜௚௛ቇ , 
3.1.1
 
where ݊௟௢௪	and  ݊௛௜௚௛	denote the lower and higher optical density materials respectively. 
However, a non-radiative electromagnetic field confined at the interface called the evanescent 
field still slightly penetrates a few hundred nanometers into the medium of lower refractive 
index and decays exponentially with distance from the surface. As the light is totally reflected 
for angles	Θ௜௡௖௜ௗ௘௡௧	 ൐ Θ௖௥௜௧௜௖௔௟, then the penetration depth of the evanescent wave can be 
adjusted by a few hundred nanometers [85]. Using this evanescent wave to excite fluorophores 
near the surface enables high contrast as the background signal of fluorophores from the bulk 
is significantly reduced.  
 
Figure 3. (a) A Jablonski diagram illustrating the concept of fluorescence on an energy plot. (b) 
Examples of two fluorophores used as lipid conjugated markers in this research – Rhodamine-PE and 
spDIO (only the fluorescing subunit is shown for clarity). Each fluorophore is overlaid with their typical 
excitation (left) and emission (right) wavelengths. 
In this thesis work, an inverted TIRF microscope was used to image the sample from 
below, through a transparent borosilicate glass substrate (as shown on Figure 4). Lipid vesicles 
and SLBs were imaged with this TIRF setup by incorporating two different types of 
fluorescently-labelled molecules. The vesicles used in the experiments to form SLBs 
incorporate a fraction of fluorophore-conjugated lipids (Rhodamine-PE), labeled at the 
hydrophilic head-group of the lipid. However, these lipid-dyes cannot be used with native 
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membranes without disturbing the membrane environment, as they need to be mixed in via 
sonication or similar. Therefore, of particular interest is how lipophilic membrane-staining 
dyes, such as DiO and DiI, which have been utilized routinely to label cell membranes without 
negatively affecting membrane fluidity [86,87], incorporate into complex BNPs, and how this 
incorporation depends on particle size, type and molecular composition. Consequently, in the 
work planned to summed up in Papers II, SUVs, NMVs and iHSV1 were labelled with the 
lipophilic membrane-staining dye SP-DiOC18(3)2 (hereafter spDIO) which is weakly 
fluorescent in water but highly fluorescent and quite photostable when incorporated into a lipid 
membrane. 
 
Figure 4. Working principle of TIRF microscopy, highlighting the main components. An off-axis light 
source is used to impact the sample at a large enough angle to fulfill the total internal reflection 
condition, resulting in the generation of an evanescent wave, exciting the fluorophores near the surface. 
A filter cube consisting of an excitation filter, dichroic mirror and an emission filter is present to select 
and direct the appropriate wavelengths for the fluorophore used, to isolate and image the fluorophore 
emission from the excitation source. 
                                                 
2 3,3’-Dioctadecyl-5,5’-Di(4-Sulfophenyl)Oxacarbocyanine 
19 
 
3.2 Microfluidics 
Microfluidics, as the name states, is the manipulation of fluids in channels with dimensions in 
the range of micrometers (1-100µm). In doing so, capabilities that are afforded through the use 
microfluidics which bulk chemistry cannot provide include, but are not limited to: (i) the ability 
to handle very small volumes of liquids (10-9 to 10-18 liters) and thus, reduce the consumption 
of samples, solvents and reagents, (ii) laminar flow (characterized by low Reynolds numbers), 
(iii) high resolution and sensitivity in separation and detection, and (iv) finely controlled flow 
rates. These unique characteristics can be utilized to promote hydrodynamic shear flow that 
induces movement of molecules attached to a SLB [88], as discussed in Paper II.  
A simple straight microfluidic channel was fabricated from the optically transparent soft 
elastomer poly-(dimethylsiloxane) (PDMS) using soft-lithography, which is a simple 
fabrication method based on a molded PDMS stamp [89]. This channel was used in Paper II to 
enable controlled fluid flows, whereas punched PDMS wells were used in Paper I. 
3.3 Size Determination 
A multitude of crucial interactions and functions of biological nanoparticles are based on their 
size. As a result, there is a need to develop sensitive and powerful particle size determination 
characterization techniques that are capable of detecting sub-200 nm particles and vesicles. 
Current state-of-the-art particle sizing technologies take advantage of the thermal motion of 
particles, known as Brownian motion. This random movement of particles was first identified 
by Robert Brown when he observed small particles ejected from pollen grains undergoing 
continuous, random motion when dispersed in water. This movement is characterized by 
rapidly changing velocities due to random collision between solvent molecules, which are in 
constant thermal motion with a thermal energy in the order of	݇஻ܶ. Collisions between 
dispersed NPs and solvent molecules occur in all directions and at all interfaces in a motion 
known as a random walk, first characterized by Albert Einstein in 1905 [90]. Einstein 
determined that the Brownian motion of particles relate to their diffusivity, ܦ, through their 
mean squared displacement (MSD), which is the measure of particle deviation from its 
reference position as a function of time [90–92]: 
ܯܵܦሺݐሻ ൌ 〈ሺ࢘ሺݐሻ െ ࢘଴ሻଶሻ〉 ൌ 2݀ܦݐ , 3.3.2
where ݀ is the number of dimensions (2 in our case), ࢘଴	is the reference position of the particle 
and ࢘ሺݐሻ the position at time t. It is important to note that the MSD scales linearly with the 
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diffusivity, hence allowing one to extract the diffusivity from a linear fit of the curve. The 
probability distribution of such a particle’s displacement follows a Gaussian shape [90].  
Most commonly the MSD of an individual particle can be estimated from its 
experimentally measured trajectory for a given duration ݊∆ݐ	(lag time) as follows [91,93,94]: 
ܯܵܦሺ݊∆ݐሻ ൌ 1ܰ െ ݊ ෍ሺ࢘௜ െ ࢘௜ା௡ሻ
ଶ
ேି௡
௜ୀଵ
, ݊ ൌ 1, … , ܰ െ 1 , 3.3.3
where ܰ is the number of frames, ࢘௜ the particle position at frame ݅, whereas  ࢘௜ା௡ the particle 
position after ݊ frames and ∆ݐ	the time interval characterized by the frame rate 1/∆ݐ. 
Einstein also showed, among others [95,96], how the aforementioned diffusivity relates to 
the mobility of a particle [90], which is known as the Einstein relation: 
ܦ ൌ ߤ݇஻ܶ , 3.3.4
The mobility, ߤ,	of a particle is the ratio between an applied drag force	ܨ inducing a drift 
velocity	ݒ (ߤ ൌ ݒ/ܨሻ and is inversely proportional to the friction (drag) coefficient, which 
characterizes the influence of the surrounding medium. In the case of spherical particles at low 
Reynolds numbers [97], Stokes’s law [98] states that the drag coefficient is proportional to the 
(dynamic) viscosity of the medium and the hydrodynamic radius of the particle. Thus, the 
Stokes-Einstein equation can be written: 
ܦ ൌ k୆T6ߨߟݎ , 3.3.5
which shows that the diffusivity of a spherical particle depends (except for the thermal 
energy	݇஻ܶ), only on the viscosity of the solution and the hydrodynamic radius of the particle 
itself [90]. 
The aforementioned relation between the size and diffusivity of a particle (eq. 3.3.5) and 
the possibility to determine the diffusivity from the MSD of a particle’s trajectory (eq. 3.3.2) 
are fundamental for the subsequent methods, as they enable to determine the hydrodynamic 
size of NPs from their trajectories. 
3.3.1 Nanoparticle Tracking Analysis 
Nanoparticle tracking analysis (NTA) is one of the most commonly used optical methods for 
nanoparticle size determination, especially for BNPs such as extracellular vesicles [67]. 
Conventional NTA uses a focused laser beam to illuminate particles in a suspension. The 
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particles within the beam scatter light in every direction. This scattered  light by each particle 
in the field of view can then be collected by an objective placed above the sample, fitted to an 
otherwise conventional optical microscope [76]. The scattered light is captured by a high-speed 
camera, where the particles ongoing random walks in three dimensions will be visualized as 
bright/illuminated spots in the field of view. This facilitates individual identification and 
analysis of single particles by firstly calculating the diffusivity from its two-dimensional MSD 
(eq. 3.3.2). From this, the hydrodynamic radius of each particle is extracted using the Stokes-
Einstein equation (eq. 3.3.5): 
ܦ ൌ ݇஻ܶ6ߨߟݎ
௬௜௘௟ௗ௦ሳልልሰ ݎ ൌ ݇஻ܶ6ߨߟܦ 3.3.6
From this, it is evident that particle diffusivity is inversely proportional to the size of the 
particles; hence, smaller particles diffuse faster and the diffusivity increases as a function of 
increasing temperature and decreasing viscosity. 
Since conventional NTA operates in scattering mode, with few operating in both 
fluorescence and scattering mode [69], this size determination method is therefore highly 
dependent on the refractive index of the particle [99]. Subsequently, for high refractive index 
materials such as gold, the smallest detectable size is ~30nm, whereas the typical size 
detectable for low refractive index materials, such as lipid vesicles, typically ranges from 70 
nm to 1µm [59,70] with some examples of size determination down to 50 nm [75]. The upper 
size limit is due to the inherently slow diffusion of particles larger than ~1µm, which renders 
accurate size determination challenging.  
Furthermore, there are additional limitations associated with detecting and quantifying 
particle size distributions using NTA. The trajectory of particles within solution can only be 
observed as a two-dimensional projection. However, particles are free to move within solution 
in three-dimensions which causes particles to move in and out of the focal plane. This 3D 
movement of particles leads to significant errors in the position determination since off-focus 
particles scatter less than when they are confined within the focal plane. Such particles appear 
faint or are lost from the field of view altogether. The latter is even more dramatic for smaller 
NPs, which diffuse faster and have a lower intensity due to a smaller scattering cross-section. 
Furthermore, particles that are moving in and out of the focal plane, may be re-counted by the 
algorithm, thus leading to skewed size distributions towards smaller particles.    
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In principle, NTA can be utilized to estimate the size of a NP based on the fluorescence or 
scattering intensity. However, this is dependent on the NP remaining within the focal plane 
throughout the measurement. Since particles are not confined within two dimensions and 
therefore move in and out of focus, it is rendered difficult to accurately measure their intensity. 
The 3D movement of particles leads to significant variance in the intensity signals, thus 
creating unwanted artefacts when attempting to correlate intensity with NP size [100].  
 
3.3.2 2D Flow Nanometry 
The limitations associated with conventional NTA can be overcome by confining and 
restricting the movement of NPs within two dimensions. This was achieved recently by our 
group by coupling NPs to a fluidic interface, such as an SLB, and thereby enabling the particles 
to remain within the focal plane for longer residence times [10]. This technique, known as two-
dimensional flow nanometry (2DFN), improves the accuracy of intensity and diffusivity 
estimations substantially, compared to NTA, allowing for precise size determinations of NPs 
20-400 nm in diameter. 
In order to couple NPs to a fluidic interface, a linker, such as DNA, must be inserted within 
the membrane of lipid NPs to allow for tethering to a SLB containing mobile complementary 
DNA. Due to this tethering approach, the theoretical principles used in NTA cannot be applied 
directly for 2DFN, as the lateral diffusivity of the linker-NP system is controlled mainly by the 
linker molecule [35], which is significantly slower than a freely moving NP in solution. 
Specifically, the mobility of tethered particles is defined by the number of NP anchors that are 
coupled to the fluid interface. In 2DFN, this limitation is overcome by studying the motion of 
fluorescently-labelled BNPs tethered to a SLB when subjected to a shear flow using a 
microfluidic channel. In brief, by introducing hydrodynamic shear flow parallel to the SLB, 
the in-plane movements of BNPs can be monitored using total internal reflection (TIRF) 
microscopy. In doing so, the individual size of the SLB-tethered BNPs can be elucidated by 
analyzing their trajectories when subjected to a shear flow [10], the physical principle of which 
is summarized below. 
When a bulk flow of liquid is applied above a planar SLB, the lipid bilayer and its 
constituents move in the direction of the bulk flow [101] and different sized components move 
with markedly different velocities. The mobility, ߤ,	of a particle can be deduced from a laminar 
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bulk flow induced shear force ܨ௦௛௘௔௥,	which creates a directed movement of the particle in the 
flow direction [90]:   
μ ൌ ݒ௫ܨ௦௛௘௔௥ , 
3.3.7
where 	ݒ௫	is the flow-directional velocity of the particle. Hence, it can be inferred that a larger 
force will cause an increase in the particle’s velocity. One should also note that the flow 
directional shear force is equal to the opposing drag force, when the particle is moving at a 
constant velocity. Furthermore, according to Einstein’s relation (eq. 3.3.4), the mobility is also 
directly related to the diffusivity [90]: 
ߤ ൌ ܦ݇஻ܶ , 
3.3.8
Thus, the movement of a NP tethered to an SLB under an applied shear force can be 
divided into two components: (i) directed, non-random NP movement in the flow direction 
induced by the shear force, and (ii) random movement perpendicular to the flow due to lipids 
diffusing and interacting with the linker in the membrane. Combining the previous equations 
3.3.7 and 3.3.8 yields: 
ܦ
݇஻ܶ ൌ
ݒ௫
ܨ௦௛௘௔௥ , 
3.3.9
By deducing the flow-directional velocity of the NP from the linear increase of the 
x-position and by measuring the individual trajectories, i.e. MSD of tethered NPs in the xy-
plane to extract the diffusion coefficient and (Figure 5), the hydrodynamic shear force acting 
on the NP can be estimated.  
Furthermore, the shear force is related to the hydrodynamic radius ݎ	of a small spherical 
particle moving in a viscous fluid under laminar flow via Stokes’s law [98]: 
where ߟ	is the dynamic viscosity of the surrounding medium, ݒ௫	the average velocity of the 
particle and ܨ௦௛௘௔௥	the shear force acting on the particle.  
ܨ௦௛௘௔௥ ൌ 6ߨߟݒ௫ݎ , 3.3.10
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Figure 5. Characteristic track of a tethered BNP, showing the x-directional motion being dominated by 
a directed movement while the y-directional motion follows random Brownian motion. 
Although this equation is valid for a simple (non-tethered) system, some assumptions still 
need to be made to determine the size distribution of NPs tethered to an SLB. Firstly, the 
channel height is much larger than the hydrodynamic size of the particle, resulting in a lower 
flow velocity close to the surface. This is due to the fact, that bulk flow velocity will be larger 
in the center of the channel than at the walls, floor or ceiling [102]. For laminar flows, the fluid 
motion is assumed to be a uniform linear shear flow [103–105], hence the macroscopic fluid 
velocity can be approximated to increase linearly away from the surface (Figure 6a) [101]. 
Secondly, it is usually assumed that the flow velocity of a viscous fluid close to a surface must 
be zero, as mass cannot penetrate the solid surface and the cohesive forces between the 
molecules of the fluid are overcome by their adhesion to the surface [102]. However, there are 
several reports claiming that this so-called “no-slip” boundary condition is not strictly valid in 
all scenarios [106–109], thus a slip length must be introduced. The slip length	ߣ	can be 
described as an imaginary distance below the surface where the no-slip boundary condition 
would otherwise be satisfied (Figure 6a) [109] and can also include the length of the linker 
molecule. Taking these two assumptions into account, the flow-directional velocity ݒ௫	at the 
center of the tethered NP can be presented as: 
ݒ௫ ൌ ݒ଴ሺݎ ൅ ߣሻ ,   3.3.11
where ݒ଴	is the laminar flow velocity away from the surface and	ݎ	the hydrodynamic radius of 
the NP. Consequently, by combining equations 3.3.10 and 3.3.11, the shear force ܨ௦௛௘௔௥	acting 
on a particle in a 2DFN experiment can be determined via: 
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ܨ௦௛௘௔௥ ൌ ܣߟݒ଴ݎሺݎ ൅ ߣሻ 3.3.12
where A is a constant that accounts for the channel geometry and possible inhomogeneous flow 
profile around the NP. It should be noted that neither ܣ	nor ߣ	depend on the shape or size of 
the NP and can be determined via calibration with NPs of known size for a specific channel 
geometry. 
Thus, by measuring the individual trajectories of BNPs, the flow-directional velocity of a 
nanoparticle (ݒ௫ሻ and the average diffusivity of the NP-linker system (ܦሻ can be found. 
Consequently, if the latter two are known, the hydrodynamic shear force acting on each tracked 
NP can be directly determined via eq. 3.3.9. The shear force, along with the determined 
calibration parameters, can subsequently be used to determine the hydrodynamic size of the 
bound nanoparticles without directly probing a signal proportional to their size (Figure 6b). 
 
 
Figure 6. (a) A BNP tethered to a SLB via DNA linkers, experiencing a laminar shear flow, inducing 
a shear force causing the particle to move in the flow direction. ߣ indicates the slip length. 	(b) NMV 
size distribution acquired with 2DFN. 
2DFN offers several key advantages as a size determinant technique, compared to 
conventional NTA. One clear advantage of 2DFN is the ability to accurately quantify the 
fluorescence intensity of BNPs. This is done by confining BNPs onto a surface in a TIRF 
microscopy setup, which allows the probing of only those fluorescently labeled BNPs that are 
coupled close to the surface. Furthermore, for BNPs with a homogenous surface dye 
concentration such as vesicles containing lipid-conjugated dyes, the TIRF intensity is expected 
to be proportional to their size [110]. Therefore, it is possible to correlate the fluorescence 
intensity of BNPs to their independently determined size. Despite this, it is speculated that dye 
distribution is commonly inhomogeneous in more complex biological systems, such as viruses 
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and exosomes, where lipid-conjugated dyes cannot be used. Thus in Paper II, it was the 
intention to use the aforementioned technique combined with TIRF microscopy to determine 
the size, independent of fluorescent intensity, of the following BNP systems: artificial lipid 
vesicles, NMVs and enveloped herpes simplex virus type 1 (HSV1). Due to problems to tether 
NMVs and HSV1 to the membrane, results for these systems remains to be included.  
3.3.2.1 Data analysis 
The data analysis of 2DFN is very sensitive to several parameters, which will be discussed 
more thoroughly below.   
One such parameter is distance cutoff, determining whether it is a unique particle that is 
followed, i.e. if it belongs to a unique track, which is defined by a maximum distance between 
two ‘particles’ in two consecutive frames. This value is dependent on the surface coverage of 
the particles, since in order to avoid linking of two different particles in close proximity it must 
be lowered when the density is high. This value is selected by using a large distance cutoff and 
plotting all mean squared displacements. By linearly fitting the initial data points, it is possible 
to evaluate where the true tracks meet the noise (the false linking events). This intersection 
(Figure 7) then defines the cutoff value that is used in the analysis.  
 
Figure 7.  Logarithmic representation of the normalized count as a function of MSD. The cutoff value 
is evaluated at the intersection where the linear fit (red line) crosses the average noise, which in this 
case is 50.   
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For accurate intensity determination, several parameters which help mitigating the 
influence of potential bleaching and other factors have to be chosen very carefully, since the 
resulting intensity distribution can be affected by several factors, such as uneven illumination, 
tracking errors, dye transfer to the SLB and mode of illumination (TIRF vs. EPI). Due to the 
aforementioned factors, the intensity of an individual particle can fluctuate quite significantly 
along the particle trajectory as it moves across the field-of-view. Typically, the average 
intensity throughout the whole trajectory is measured, but this would result in unnecessary 
fluctuations. Therefore, to lower the fluctuations, the intensity was determined in the middle 
100px of the field-of-view, where the TIR light hits the sample and consequently results in the 
highest signal-to-noise. Furthermore, to remove any potential tracking errors, which cannot be 
excluded with the distance cutoff, e.g. the linkage of two particles which are in close proximity, 
tracks with unreasonably large fluctuations around their average intensity value were removed. 
This was done by first measuring the intensity over time for a few immobile particles per 
movie. The particle with the highest standard deviation relative to its mean value was used as 
an upper limit, to include everything below that value in the intensity versus size graph. 
Specifically, this relative standard deviation of the intensity ranged between 10-25%. Last, only 
particles which were present in the beginning 1/3 of the field-of-view, were included in the 
analysis to exclude particles which are lost during tracking and may later be found again, thus 
resulting in double-counting. However, this condition will often only marginally affect the 
result, as the other conditions are sufficient to remove any tracking errors.  
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4 Results 
The findings addressed in this thesis are captured in two papers, which are summarized and 
detailed below. 
4.1 Paper I 
Supported lipid bilayers (SLBs) mimic several key features of cellular membranes, such as 
planar geometry and fluidic freedom. In all studies concerning SLBs, the quality of the SLB is 
a critical factor that influences its function and utility. Therefore, significant efforts have been 
invested to gain an in-depth understanding of the SLB formation process [26,27,111–116]. 
Further, utilizing SLB’s as a core of our measurement approach (Paper II), places specific 
weight upon highly reproducible SLBs. Therefore, in Paper I, we employed TIRF microscopy 
to study the SLB formation process and kinetics on borosilicate glass. In comparison to how 
fluorescence microscopy was previously employed to study SLB formation [117,118], we 
labelled only a small fraction (1%) of the vesicles, allowing the individual adsorbed vesicles 
and SLB patches to be monitored simultaneously, by simultaneously increasing the optical 
contrast between SLB patches and their surrounding regions [56]. Resolving individual 
vesicles allowed the entire SLB formation process to be observed, from individual vesicles to 
small SLB patches, and finally coalescence to a full SLB. To quantify the individual SLB patch 
evolution and variances in patch-growth scenarios, the boundary of each patch was measured 
for each analyzed time point and subsequently used to calculate the average front velocity. It 
was concluded from our analysis that the average front velocity increases dramatically, up to 
one order of magnitude, despite the fact that the surface density of adsorbed vesicles increases 
only marginally by about 8% (Figure 8). This finding is considered significant as typically the 
front velocity of a spreading lipid mono-or bi-layer front on hydrophobic and hydrophilic 
surfaces, respectively, is either decreasing or stagnant over time [119–121]. 
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Figure 8. Typical patterns observed during the SLB patch growth and the corresponding dependence 
of the average front velocity with time: (a) single patch formation and expansion (snapshot interval 
60 s), (b) small patches merging into a bigger patch (snapshot interval 24 sec), and (c) propagating SLB 
front (snapshot interval 30 sec). Scale bars represent 20 µm. The color of the perimeter lines used in the 
images, indicates the local front velocity of the SLB patch. 
To theoretically address the rate of SLB growth, two different scenarios regarding the 
incorporation of lipids into the SLB patch after the rupture were examined: local relaxation 
and global relaxation. In the local relaxation scenario, the lipids belonging to a ruptured vesicle 
are assumed to form a circular SLB, where the growth is restricted to the immediate vicinity of 
each ruptured vesicle. In this scheme, no significant lipid rearrangement in newly-formed 
patches occurs, implying that the overlap with the existing SLB patches can be interpreted as 
either a double bilayer or material loss. In the global relaxation scenario, all lipids from 
ruptured vesicles will instead rapidly diffuse along the substrate and merge with the patch 
inducing their rupture, resulting in a circular SLB. The majority of the experimental 
observations followed the global relaxation model, manifesting in increasing front velocities 
(Figure 8). The global model also describes the observed cases, where the local coverage of 
vesicles was low. In these cases, the growth halted until more material for sustainable growth 
was introduced.  
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4.2 Paper II 
The development and advancement of novel nanoparticle size determination and 
characterization techniques is integral for improved understanding of cellular processes 
involving biological nanoparticles (BNPs), such as cellular communication and viral infections 
[2,50,53,122]. Since BNPs are usually highly heterogeneous in nature, there is a demand for 
techniques that provide simultaneous information of multiple parameters, such as size and 
concentration, preferably with single BNP resolution. In an attempt to achieve this, TIRF 
microscopy was combined with microfluidics, in Paper II, to study a BNP model system 
consisting of fluorescently-labelled liposomes tethered to a supported lipid bilayer (SLB). 
Two-dimensional flow nanometry (2DFN) was utilized in this approach by applying shear 
force to the liposomes, allowing for the Brownian motion of tethered liposomes to be decoupled 
from their directed motion. In doing so, the hydrodynamic size and fluorescent emission could 
be determined independently for each tracked liposome [10].  
In previous work, it was verified that fluorescence intensity could be correlated to 
liposome size for a fluorescent lipid-dye (Rh-POPE), which was incorporated during vesicle 
fabrication/generation [10]. However, dye-labeled lipids cannot be incorporated into native 
membranes without severely disturbing the lipid organization, since they need to be combined 
by lysing the membrane through sonication or similar. Subsequently, the objective of Paper II 
was to utilize 2DFN to independently derive the size and fluorescence intensity of model BNPs 
with varying complexities, ranging from artificial liposomes to viruses, using the lipophilic-
staining dyes, spDIO and PKH, which have been routinely utilized to label cell membranes 
without negatively affecting membrane fluidity [86,87]. Despite the extensive use of lipophilic 
dyes, it still remains unclear how they are incorporated into complex BNPs, and how this 
incorporation depends on particle size, type and molecular composition. Subsequently, specific 
emphasis was placed on investigating the correlation between the dye incorporation efficiency 
and BNP size.  
 To address this, a model system consisting of liposomes containing either lipophilic dye, 
spDIO or PKH, was used to measure the incorporation efficiency of the dye in the liposome. 
This was achieved by quantifying and relating the fluorescence intensity emitted by the 
liposomes to their sizes on an individual level. For all of dyes used, the fluorescent intensity of 
the liposomes scaled with their surface area, making the approach highly feasible for qualitative 
determination of incorporation efficiencies of fluorescent dyes. Figure 9 shows how the size 
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and intensity of spDIO-labelled POPC indeed follows the expected dependency. We also 
addressed the issue of nonspecific binding on lipid vesicles to the SLB, and discuss the 
appropriateness of the inclusion of these nanoparticles into the analysis. It can thus be 
anticipated that other lipophilic dyes, with a similar molecular composition, will behave in a 
comparable manner. For more complex, real BNPs, labelled with lipophilic dyes, this scaling 
is however not obvious, as also indicated from results obtained using spDIO and NMVs. 
 
Figure 9. a) Size distribution determined using 2DFN (blue) of spDIO-labelled DNA-tethered vesicles 
fitted to a log-normal distribution (red). b) Fluorescence intensity versus hydrodynamic radius (blue 
dots) for spDIO-labelled DNA-tethered liposomes 
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5 Future outlook 
In addition to paper I and II included in the licentiate thesis, there are several other ongoing 
and prospective projects furthering nanoparticle characterization, which will be discussed 
below. 
5.1 Size and intensity correlation of complex BNPs 
Several BNPs were studied in the context of this thesis – Rhodamine, PKH and spDIO labelled 
POPC vesicles, as well as spDIO labelled NMVs, EVs and iHSV1s. However, the experiments 
were always not as straightforward as one would hope. Since the 2DFN approach typically 
requires a tethering chemistry, such as cholesterol DNA, it is necessary to know the 
concentration of the stock BNP. However, the concentration of complex BNPs samples is 
typically unknown and can differ from sample-to-sample. Nonetheless, NTA was used in these 
cases to estimate the number concentration of EVs and iHSV1. Moreover, in a typical 2DFN 
experiment approximately 3-10 tethers per BNP should be used depending on the size of the 
particles, to ensure linker-dominated diffusivity while still retaining sufficient mobility 
[10,123]. To illustrate a common challenge, we aimed at taking these two factors into account 
when EVs were incubated with cholesterol-DNA to achieve 6, 12, 30, and 60 DNAs per 
particle. Subsequently, EVs with increasing tether concentrations were introduced to the flow 
channel containing a complementary cholesterol-DNA incubated SLB. However, no binding 
was observed in any of these cases, although the particles were clearly visible in bulk. One of 
the reasons for the absence of binding could be insufficient amount of tethers per particle, since 
the stock and consequently incubation concentration of EVs determined from NTA compared 
to POPC was over 50 times lower. If the true EV concentration is significantly higher (NTA 
does not detect vesicles below a certain size), the concentration of cholesterol-DNA used to 
modify the EVs might have been too low. This is however quite unlikely, since cholesterol-
DNA should have enough time to diffuse and incorporate into EVs within the incubation time 
and since one cholesterol-DNA per vesicle should be enough to observe at least transient 
binding. However, the reasoning is based on the reasonable assumption that self-insertion of 
cholesterol-DNA into phospholipid membranes is efficient in EVs. In fact, self-insertion of 
amphiphilic compounds like cholesterol-DNA may very well be hindered by the already high 
membrane cholesterol content of these native BNPs, making them effectively highly rigid 
particles. In fact, after EVs were incubated with spDIO, a visual red-shift (from yellow to pink) 
in the color of the sample was observed. The latter could be caused by a high amount (~30%) 
of cholesterol in the membrane of the EV, also obstructing the subsequent cholesterol-DNA 
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incorporation into the membrane. In turn, the free cholesterol DNA in the EV solution 
potentially covered most of the available binding sites on the SLB. Interestingly, the post-
labelled EVs were exceptionally bright compared to POPC vesicles, ensuring the applicability 
of these lipophilic dyes for complex BNP labelling. In future work, we will put focus on 
alternative tethering schemes, such as cholesterol-modified PEG with a biotin anchor for 
binding to streptavidin on an SLB or only electrostatic attraction (see Paper II). These issues, 
which were also observed for HSV1 and NMVs, stimulated the use of the high throughput 
device described in the next section, in which case there is no need for a tethering chemistry. 
 
5.2 High throughput device 
Another ongoing project is the characterization of exosomes and other BNPs in a high-
throughput device. Contrarily, with this method, individual particles are confined in high-
aspect ratio nanochannels of 300 nm in both width and height, but several millimeters in length. 
As the particles are of similar size-scale to the channel cross-section, they will be unable to 
diffuse perpendicularly along the flow and will experience hindered diffusion [124] However, 
the size of BNPs can be still estimated from their flow-directional diffusivity by taking the 
aforementioned corrections into account. Furthermore, as these NPs stay within the focal plane, 
the intensity determination will be similar to the 2DFN case. This will enable the determination 
of size and intensity distributions of different BNPs in a high-throughput manner. Figure 10 
shows a dataset with Rhodamine-labelled vesicles, depicting a correlation between the size and 
concentration of these particles. Furthermore, the size distribution in this case does not need 
adjustment or calibration, as the size of each BNP is calculated directly from their diffusivity 
according to equation 3.3.6 by taking into account the effect of the walls [124], illustrating the 
applicability of this method for non-tethered nanometer-scale biological systems 
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Figure 10. Analysis of Rhodamine-labelled vesicle (a) size distribution with a log-normal fit (line) and 
(b) intensity versus hydrodynamic radius dependence determined using the hindered diffusion model. 
The fit demonstrates an r2 dependence, with an R-square value of 0.45.  
5.3 Concentration determination 
In addition to size, molecular content and structure, one would also like to acquire information 
about the concentration of BNPs, since it is believed that the concentration of specific EVs, 
e.g. exosomes, is altered for patients affected with disease compared to healthy subjects [125]. 
Recently, Rupert et al. used surface plasmon resonance spectroscopy to determine exosome 
concentration in solution from the rate of exosome binding under diffusion limited conditions 
[126]. We planned to further this research by measuring both the rate binding of individual 
vesicles to an SLB combined with the 2DFN approach described in section 3.3.2 and Paper II. 
The adsorption kinetics of vesicles can be investigated by either directly measuring the rate of 
binding to a surface or to an SLB via tethering-chemistry. The rate of adsorption to the surface 
can follow two pathways: (i) reaction-limited binding, where the binding kinetics is determined 
by the actual binding to the surface or (ii) diffusion-limited binding, where the binding to the 
surface is so fast that the rate of binding is controlled by diffusion across a depletion zone near 
the surface. For rectangular flow geometry, the mass transfer to the surface can be characterized 
by the mass-transport coefficient [127,128]: 
݇ெ ൌ 0.98 ൬ܦ௜݄ ൰
ଶ
ଷ ൬ ܳݓ݈൰
ଵ
ଷ, 5.3.1
where ܦ௜	is the diffusion coefficient of the vesicle population with size ݅, ܳ 	the volumetric flow 
rate , and h, w, l	are the height, width, and length of the channel, respectively. The rate of 
binding is then proportional to the analyte concentration according to [111,129]:  
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Γ୧
∆ݐ ൌ ݇ெܥ௜ , 
5.3.2
where Γ௜/∆ݐ	is the rate of binding per surface area of vesicle subpopulation with size ݅	and ܥ௜	is 
the concentration of the corresponding subpopulation. However, the adsorption rate to the 
surface under flow conditions may differ at various points on the surface, depending on the 
distance from the inlet to the measurement area [111]. Therefore, we designed a PDMS chip 
(Figure 11a) to minimize effects from depletion and buildup of a depletion layer, which can be 
caused due to liquid passage between the measurement area and the sample container. In order 
to test the PDMS chip design, we measured several time series of Rhodamine-labelled POPC 
vesicles binding to the glass floor of a microfluidic chip. Figure 11b shows two binding 
experiments with the same flow rate, but in different regions of the PDMS chip. The higher 
rate of binding was observed in the second region of the channel, which consequently lead to 
differences in the calculated concentrations. The concentration was calculated according to eq. 
5.3.2 and compared to the concentration value estimated from the molar concentration of 
vesicles in the prepared solution. The latter was estimated by using the mode size from NTA 
to calculate the amount of lipids per vesicle. While comparing these two values an average of 
92% (out of >10 experiments) of the prepared concentration was achieved in the second region 
of the channel. In principle, this result suggested that the chip design was suitable for further 
experiments. However, 30% of the cases were outliers, being off by a factor of 2. The 
discrepancy between the prepared concentration and the concentration calculated using eq. 
5.3.2 can be attributed to several factors. First, some material may be lost through sample 
preparation e.g. extrusion and subsequent dilution steps. However, a more probable reason to 
the discrepancy is the assumption of using the mode value from NTA to estimate the prepared 
vesicle concentration. This could be overcome by taking into account the whole NTA size 
distribution in the calculation of the initial vesicle concentration from the dry lipid 
concentration.  
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Figure 11. Microfluidic flow chamber specifics (a) Schematic of the channel geometry. Two equal 
flows of the sample from inlet 1, and buffer from inlet 2, are introduced simultaneously. During this 
introduction, a fluorescent time series of images is taken in the 1st region. Following this, outlet 3 is 
closed, and inlet 2 is opened. Another time series is taken in the 2nd region. (b) Number of detected 
vesicles within the 1st (black dots) and 2nd (red squares) regions of the channel plotted versus time, for 
a 100 × 100 μm2 surface area. 
This approach can in principle be extended to BNP binding to an SLB. However, it 
remains difficult to combine both the size and concentration determination in one experiment, 
to in that way determine both the concentration of differently sized particle sub-populations 
and molecular content. In order to ensure mass-transport limited conditions, a high-affinity 
binding chemistry such as neutravidin-biotin is needed. However, particles tethered in this way 
are not easy to shear with a hydrodynamic flow. Another option is to continue with DNA-
tethering, with mobile vesicles as was done in 2DFN. This might switch the rate of binding to 
the reaction-limited regime, but it may increase the possibility of elucidating the concentration 
by determining the rate for the reaction limited binding process. Alternatively, as the 2DFN 
method can be used to determine if a specific BNP-dye combination incorporates 
proportionally to particle size (Paper II), this approach could be combined with the 
concentration determination of BNPs obtained from the rate by which they bind to the surface. 
In this way, one could thus determine both the concentration and individual size of complex 
BNP sub-populations. In either case, this would enable for the method to become truly multi-
parametric, by enabling one to determine the size, concentration and molecular content – all in 
one experiment.  
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5.4 Native drug-delivery vehicles 
Since drug delivery vehicles made of synthetic lipid encounter a multitude of limitations for in 
vivo applications, much interest has been focused on harnessing BNPs for drug-delivery 
applications [130]. For example, limitations such as poor uptake and non-specific drug release 
can potentially be overcome by using NMVs (more thoroughly discussed in section 1.3.3), 
which are obtained via mechanical cell lysis [56], or exosomes [131]. Compared to synthetic 
vesicles, NMVs have high biocompatibility, long retention time in vivo and efficient cellular 
uptake [132]. Further, NMVs can be combined with mesoporous silica nanoparticles (MSNs) 
which have several beneficial properties – tunable size, high stability, high biocompatibility, 
high drug loading, and controlled drug release [133]. In future work, we will explore this 
possibility by sonicating NMVs together with MSNs, similarly to how synthetic vesicles were 
previously used for the same purpose [134]. To validate if the MSNs are lipid coated, both 
membrane dyes and TEM will be used (having uncoated bare particles as the control) [135]. If 
protocols can be found to ensure the encapsulation of MSNs was effective, we plan to 
determine if cellular uptake of native MSNs is increased in vivo, compared to non-native 
protocells. 
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